Related Experiment Video
Updated: Dec 11, 2025
07:40
Gene Transfection toward Spheroid Cells on Micropatterned Culture Plates for Genetically-modified Cell Transplantation
Published on: July 31, 2015
9.0K
Cyclopropenium Nanoparticles and Gene Transfection in Cells.
Noam Y Steinman1, Luis M Campos2, Yakai Feng3
1Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Pharmaceutics
|August 23, 2020
Summary
New cyclopropenium nanoparticles offer enhanced gene transfection with minimal toxicity, presenting a promising alternative to traditional non-viral vectors for advanced gene therapy applications.
Area of Science:
- Biomaterials Science
- Gene Therapy
- Nanotechnology
Background:
- Non-viral vectors are crucial for delivering genetic material in gene therapy.
- Current methods often face challenges with efficiency and toxicity.
- Quaternary ammonium compounds are common but have limitations.
Purpose of the Study:
- To introduce cyclopropenium-based nanoparticles as novel non-viral gene transfection agents.
- To evaluate their efficiency and cytotoxicity compared to existing methods.
- To explore their potential in gene therapy applications.
Main Methods:
- Synthesized cyclopropenium-based cationic nanoparticles by crosslinking poly(ethylene imine) (PEI) with tetrachlorocyclopropene.
- Complexed nanoparticles with plasmid DNA, forming ~50 nm structures.
- Assessed cellular uptake and gene expression in F929 mouse fibroblast cells in vitro.
Main Results:
- Cyclopropenium nanoparticles demonstrated enhanced gene transfection compared to PEI.
- These nanoparticles exhibited minimal cytotoxicity.
- Efficient cellular uptake and gene expression were observed in vitro.
Conclusions:
- Cyclopropenium-based nanoparticles are effective non-viral gene delivery vectors.
- They offer a promising alternative with improved transfection efficiency and reduced toxicity.
- These findings highlight their potential for future gene therapy development.
